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OBJECTIVE—The NOD mouse strain has been widely used to
investigate the pathology and genetic susceptibility for type 1
diabetes. Induced pluripotent stem cells (iPSCs) derived from
this unique mouse strain would enable new strategies for
investigating type 1 diabetes pathogenesis and potential thera-
peutic targets. The objective of this study was to determine
whether somatic ﬁbroblasts from NOD mice could be reprog-
rammed to become iPSCs, providing an alternative source of
stem cells for the production of genetically modiﬁed NOD cells
and mice.
RESEARCH DESIGN AND METHODS—Adult tail-tip ﬁbro-
blasts from male NOD mice were reprogrammed by retroviral
transduction of the coding sequences of three transcription
factors, OCT4, SOX2, and KLF4, in combination with a histone
deacetylase inhibitor, valproic acid.
RESULTS—Eighteen NOD iPSC lines were generated, and three
of these cell lines were further characterized. All three cell lines
exhibited silencing of the three reprogramming transgenes and
reactivation of endogenous pluripotent markers (OCT4, SOX2,
NANOG, REX1, and SSEA1). These NOD iPSCs readily differen-
tiated in vitro to form embryoid bodies and in vivo by teratoma
formation in immunodeﬁcient mice. Moreover, NOD iPSCs were
successfully transfected with a reporter transgene and were
capable of contributing to the inner cell mass of C57BL/6
blastocysts, leading to the generation of a chimeric mouse.
CONCLUSIONS—Adult tail-tip ﬁbroblasts from NOD mice can
be reprogrammed, without constitutive ectopic expression of
transcription factors, to produce iPSCs that exhibit classic mouse
embryonic stem cell (ESC) features. These NOD iPSCs can be
maintained and propagated under normal ESC culture conditions
to produce genetically altered cell lines, differentiated cells, and
chimeric mice. Diabetes 60:1393–1398, 2011
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OD mice spontaneously develop type 1 di-
abetes, similar to humans with this disease, and
provide a valuable model for investigating type
1 diabetes pathogenesis under controlled ge-
netic and environmental settings (1). The derivation of
pluripotent embryonic stem cells (ESCs) from the NOD
strain has proven elusive until a recent study identiﬁed
conditions for derivation and maintenance by using small
molecules that inhibit the key differentiation-inducing path-
ways (2–7).
ESC-like cells can also be generated by forced expres-
sion of deﬁned transcription factors in somatic cells, with
the resulting cells termed “induced pluripotent stem cells”
(iPSCs) (8–12). Because of their pluripotent nature, iPSCs
are amenable to gene targeting via homologous recombi-
nation and germline competency (9,13,14), making them
a promising alternative source of pluripotent cells for
producing genetically modiﬁed tissues or mice from strains
for which derivation of conventional ESCs has proven dif-
ﬁcult.
In a previous study, Hanna et al. (4) claimed the con-
stitutive ectopic expression of KLF4 or c-MYC was an ab-
solute requirement for derivation and maintenance of NOD
iPSCs. By contrast, we observed a combination of retro-
viruses encoding OCT4, SOX2, and KLF4 (OSK), despite
being silenced (15), are capable of fully reprogramming
adult NOD mouse tail-tip ﬁbroblasts (nTTFs) to generate
NOD iPSCs.
RESEARCH DESIGN AND METHODS
Mice. Mice, including NOD/Lt mice for tail-tip ﬁbroblasts isolation, were
maintained in a speciﬁc pathogen-free animal facility under Monash University
approved ethics (MMCA2007/34).
Tail-tip ﬁbroblast isolation. An ;1.5 cm length of tail-tip from 8-week-old
male NOD mice was washed with 70% ethanol and PBS, the superﬁcial
dermis was peeled away, and the remaining tissue was cut into 1-mm pieces
using a scalpel. Five or six pieces were plated in one well of a six-well plate
and cultured with 2 mL of nTTF medium (Dulbecco’s modiﬁed Eagle’s
medium with 10% FBS and 50 units/mL penicillin/streptomycin) for 5–7
days. Cells migrating out were trypsinized and expanded into T25 ﬂasks
(passage 1).
Retrovirus production and iPSC induction. Retrovirus production and iPSC
induction were performed as described previously with minor modiﬁcations
(16). Brieﬂy, pMX-based retroviral vectors (Addgene) encoding mouse OCT4,
SOX2, and KLF4 sequences were independently transfected into Plat-E cells.
The next day, nTTFs at passage 4 were seeded at a density of 1 3 10
5 cells per
well in six-well plates overnight. The virus-containing supernatants were col-
lected 48 h after transfection, mixed, ﬁltered, and added to the nTTFs together
with 4 µg/mL polybrene (Sigma-Aldrich, St. Louis, MO) for 24 h. Subsequently,
nTTFs were cultured in mouse ESC medium supplemented with 2 mmol/L
valproic acid (VPA), which was refreshed daily for 7 days.
Cell culture and colony pick-up. Mouse ESC culture medium was com-
posed of knockout-Dulbecco’sm o d i ﬁed Eagle’s medium, 20% knockout
serum replacement, 0.1 mmol/L nonessential amino acids, 1 mmol/L Glu-
tamax, 0.1 mmol/L b-mercaptoethanol (all from Invitrogen, Carlsbad, CA),
and 1,000 units/mL leukemia inhibitory factor (LIF) (Millipore, Billerica, MA).
Cells were cultured in a 37°C, 5% CO2 incubator. At day 14 after transduction,
colonies were picked individually and incubated with 20 µL of 0.25% trypsin/
1 mmol/L EDTA (Invitrogen) for 5 min at 37°C in a well. The colonies were
dissociated into single cells and transferred to wells in 96-well plates with
mouse embryonic ﬁbroblast (MEF) feeder cells and 200 µL ESC medium. The
iPSCs were further expanded in six-well plates.
Immunocytochemistry. Immunocytochemical staining was performed as
described previously (16). Primary antibodies were OCT4 (1:100, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), NANOG (1:100, Abcam, Cambridge, U.K.),
and SSEA-1 (1:100, Millipore).
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BRIEF REPORTRT-PCR and genomic DNA PCR. Total RNA was isolated using the RNeasy
kit (QIAGEN, Hilden, Germany), and genomic DNA contamination was re-
moved using DNA-free kit (Ambion, Austin, TX). One microgram of total RNA
was used for cDNA synthesis using Superscript III Reverse Transcriptase and
Oligo (dT) primers (Invitrogen).
Genomic DNA was isolated from approximately 2 3 10
6 iPSCs for each cell
line using DNeasy Blood and Tissue kit (QIAGEN). PCR was performed using
primers listed in Table 1.
Bisulﬁte genomic sequencing. Genomic DNA from NOD iPS, ES (D3 line),
and nTTF cells were extracted and processed for bisulﬁte genomic sequencing
analysis as described previously (17). Nested-PCR and sequencing was per-
formed using primers listed in Table 1.
Differentiation of NOD-iPSCs. To form embryoid bodies (EBs) in vitro,
NOD-iPSCs were dissociated into single cells and resuspended in mES medium
without LIF in bacteriological Petri dishes (Falcon, BD Biosciences) for
1 week. To form teratomas in vivo, ;2 3 10
6 NOD iPSCs were injected into the
hind leg muscle of NOD/SCID mice. Teratoma tissue was dissected out
4 weeks postinjection and processed for hematoxylin–eosin staining by the
Monash Institute of Medical Research Histology Laboratory core facility.
Blastocyst injection and embryo transfer. Host embryos were collected at
the blastocyst stage from C57BL/6 female mice at 3.5 days post coitum, and 10–
15 NOD iPSCs were injected into each. After a recovery period of ;2h ,1 0t o
15 injected blastocysts were transferred into one uterine horn of pseudo-
pregnant CBA3C57BL/6 F1 female mice at 2.5 days post coitum. Chimeric
mice were identiﬁed by coat color, and the male chimera was assessed for
germline transmission by mating with NOD female mice.
Flow cytometric analysis of splenic B cells. Single cell suspensions were
prepared from individual spleens and erythrocytes were lysed by treating the
sample with tris-NH4Cl followed by washing with FACS buffer containing 2%
FBS. FC receptor binding was blocked by incubating cells with 2.4G2 (BD
Biosciences Pharmingen, San Diego, CA). The following monoclonal anti-
bodies were used in multiparameter ﬂow cytometric analysis: anti-CD19 (6D5,
Alexa Fluor 700 conjugated) and anti-H-2K
b (AF6–88.5, PerCP/Cy5.5 conju-
gated) from Biolegend and anti-H-2K
d (SF1–1.1, ﬂuorescein isothiocyanate
conjugated), anti-I-A
g7 (OX-6, ﬂuorescein isothiocyanate conjugated), and anti-
I-A
b (AF6–120.1, phycoerythrin conjugated) from BD Pharmingen. Cells were
analyzed with an LSR Fortessa (BD Biosciences, Franklin Lakes, NJ) and FlowJo
(Tree Star) software using propidium iodide incorporation to exclude dead cells.
Microsatellite genotyping of cell lines. DNA was extracted from the NOD-
iPS#5 cell line and genotyped for 112 microsatellite markers across the mouse
genome covering 19 autosomes and the X chromosome. All markers used were
polymorphic between NOD/Lt and C57BL/6 mouse strains. Genotyping was
performed by the Australian Genome Research Facility Ltd., using the Applied
Biosystems (Carlsbad, CA) 3730 DNA Analyzer and AB Gene Mapper Software.
RESULTS
During the 7 days of VPA treatment (Fig. 1A), clusters of
cells started to aggregate together. By day 14 postviral
infection, ES-like colonies were individually picked, tryp-
sinized, and transferred to MEF feeder cells in 96-well
plates for expansion (Fig. 1B). A total of 41 putative col-
onies were picked in three replicated experiments, and 18
colonies were successfully expanded in six-well plates
(Supplementary Table 1). The cells formed compacted
colonies showing a refractile halo effect when observed by
phase-contrast microscopy (Fig. 1B), which is similar to
that observed for mouse ESC colonies. The cells were
routinely split in a 1:6 ratio every 2–3 days. The NOD-iPSCs
have been maintained for .50 passages. Next, we trans-
fected one of the NOD-iPSC lines with an mCherry ex-
pression cassette (CMV-mCherry-hygro) by LipofectaMINE
(Invitrogen) as described previously (18). After selection
with hygromycin and expansion, a stably transfected NOD-
iPS-mCherry cell line was established (Fig. 1B).
Of the 18 NOD iPSC lines generated, three were selected
for further characterization. We conﬁrmed by genomic
DNA PCR that the three reprogramming transgenes (OSK)
were integrated in the genome of the iPSCs (Fig. 1C). RT-
PCR analysis conﬁrmed that OSK transgenes were efﬁ-
ciently silenced in the three NOD iPSC lines (Fig. 1D). In
addition, reactivation of endogenous OCT4 and SOX2
genes, as well as other pluripotent-associated transcription
factors such as NANOG and REX1 (also known as ZFP42),
was observed in all NOD iPSC lines tested in the study
(Fig. 1D). Immunohistochemical analysis showed that the
iPSCs stained positively for OCT4, NANOG, and SSEA1
(Fig. 1E). Further, bisulﬁte sequencing analysis revealed
that promoter regions examined for both OCT4 and
NANOG were demethylated in NOD-iPSCs, in a manner
similar to mouse ESCs (ESD3 cell line), compared with
heavily methylated patterns observed for the same re-
gions in the parental nTTF cells (Fig. 1F), suggesting
epigenetic reprogramming to pluripotency. Karyotyping
TABLE 1
Primer sequences
Gene name Forward primers (59 to 39) Reverse primers (59 to 39)
For Tg genomic PCR and RT-PCR
Endogenous Oct4 TCTTTCCACCAGGCCCCCGGCTC TGCGGGCGGACATGGGGAGATCC
Sox-2 TAGAGCTAGACTCCGGGCGATGA TTGCCTTAAACAAGACCACGAAA
Klf4 GCGAACTCACACAGGCGAGAAACC TCGCTTCCTCTTCCTCCGACACA
Nanog TCAAGGACAGGTTTCAGAAGCA GCTGGGATACTCCACTGGTG
Rex1 GGACTAAGAGCTGGGACACG GCTGCTTCCTTCTTGAACAAT
b-actin GGAATCCTGTGGCATCCATGAAAC AAAACGCAGCTCAGTAACAGTCCG
Transgene Oct4 TTGGGCTAGAGAAGGATGTGGTTC TTATCGTCGACCACTGTGCTGCTG
Sox2 GGTTACCTCTTCCTCCCACTCCAG TTATCGTCGACCACTGTGCTGCTG
Klf4 GCGAACTCACACAGGCGAGAAACC TTATCGTCGACCACTGTGCTGCTG
For bisulﬁte-sequencing nested PCR
Oct4 1st round TTGAGGAGTGGTTTTAGAAATAATTGGTAT CCCAACCCTACTCCAACCCTACTA
2nd round GGGTAAGTAAGAATTGAGGAGTGGTTT CCCAACCCTACTCCAACCCTACTA
Nanog 1st round AAGTATGGATTAATTTATTAAGGTAGTT AAAAAACCCACACTCATATCAATATA
2nd round AAGTATGGATTAATTTATTAAGGTAGTT CAACCAAATCAACCTATCTAAAAA
For the three germ layer marker RT-PCR
Differentiation markers Nestin TCTGGAAGTCAACAGAGGTGG ACGGAGTCTTGTTCACCTGC
Vimentin GATGTTTCCAAGCCTGACCTC GGCGTTCCAGAGACTCGTTAG
GATA6 CTGAATACTTGAGGTCACTGTTCTCGGG ACCTTATGGCGTAGAAATGCTGAGGGTG
Brachyury CATGTACTCTTTCTTGCTGG GGTCTCGGGAAAGCAGTGGC
FoxA2 TGGTCACTGGGGACAAGGGAA GCAACAACAGCAATAGAGAAC
Sox17 TTTGTGTATAAGCCCGAGATGG AAGATTGAGAAAACACGCATGAC
GENERATION OF NOD MOUSE iPSCs
1394 DIABETES, VOL. 60, MAY 2011 diabetes.diabetesjournals.organalysis showed a normal chromosome number (40, XY) in
the three iPSC lines (Fig. 1G), and genome-wide genotyp-
ing (;112 microsatellite markers) of NOD-iPS #5 cell line
conﬁrmed the NOD genetic background (Supplementary
Table 2).
We next evaluated the differentiation potential of the
NOD iPSCs in vitro by EB formation and in vivo by tera-
toma induction. The iPSCs readily formed EBs on culture
in the absence of feeders and LIF (Fig. 2A). RT-PCR of the
EBs showed strong suppression of pluripotency genes in-
cluding OCT4 and NANOG, with coincident activation of
lineage-speciﬁc genes representing the three germ layers:
nestin (ectoderm); vimentin and brachyury (mesoderm);
and Gata6, Sox17,a n dFoxA2 (endoderm) (Fig. 2B). All
three NOD-iPSC lines generated well-differentiated ter-
atomas in the NOD/SCID mice. Hematoxylin-eosin staining
FIG. 1. Generation of iPSCs from nTTFs. A: Schematic representation of the experimental protocol. nTTFs were plated at a density of 1 3 10
5 cells
per well in six-well plates and infected with retroviruses encoding OSK factors for 24 h. The infected nTTFs were cultured in ﬁbroblast medium for
2 days, switched to mouse ESC medium supplemented with VPA for 1 week, and subsequently cultured in mouse ESC medium. Emerging iPSC
colonies were picked ;14 days after infection. B: Representative images of colonies observed at different stages as indicated in the panels (p,
passage number) and the representative colonies stably transfected with CMV-mCherry-Hygro construct. C: Integration of OCT4, SOX2, and KLF4
transgenes in the three OSK-induced iPSC lines was conﬁrmed by genomic PCR using transgene-speciﬁc primers, with H2O and nTTF as negative
controls and the construct plasmids as positive control. D: Expression of endogenous genes OCT4, SOX2, KLF4, NANOG, and REX1; expression of
transgenes OCT4, SOX2, and KLF4 in the tail-tip ﬁbroblasts; and the three OSK-induced iPSC lines were assessed by RT-PCR, with H2O as negative
control and appropriate samples as corresponding positive controls. b-Actin was used as a loading control. E: Immunoﬂuorescence staining shows
expression of pluripotency markers (OCT4, NANGO, and SSEA1) in the three OSK-induced iPSC lines. F: Methylation analysis of OCT4 and
NANOG promoter regions. Genomic DNA from mouse ESCs (ESD3), ﬁbroblasts (nTTF), and the three OSK-induced iPSC lines were processed for
bisulﬁte sequencing. Each horizontal row of circles represents an individual sequencing result from one amplicon. Open and ﬁlled circles indicate
unmethylated and methylated CpG dinucleotides, respectively. G: Karyotype of the three OSK-induced iPSC lines. (A high-quality digital repre-
sentation of this ﬁgure is available in the online issue.)
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germ layers, including keratinized-epithelium (ectoderm),
cartilage (mesoderm), and secreting-gland epithelium (en-
doderm) (Fig. 2C). Immunohistochemical staining of ter-
atomas conﬁrmed differentiation to the three germ layers
(Supplementary Fig. 1).
A total of 24 C57BL/6 blastocysts injected with NOD-
iPS#5 cells were transferred into the uteri of two pseudo-
pregnant mice. Both recipients became pregnant and
delivered a total of 17 pups, with one male pup (designated
as XA2401) showing 40–50% coat color chimerism (Fig.
2D). We crossed the chimeric male with wild-type NOD
FIG. 2. Differentiation of NOD iPSCs and chimera analysis. A: In vitro differentiation of CMV-mCherry-Hygro vector transfected NOD iPSCs to EBs
(bright ﬁeld and ﬂuorescence ﬁeld). B: RT-PCR analysis of total RNA isolated from EBs generated from the three NOD iPSC lines, one NOD iPSC
line (No. 5), and nTTF. The expression of Oct4 and Nanog (pluripotency markers); vimentin and brachyury (mesoderm); Gata6, FoxA2, Sox17
(endoderm markers); and nestin (ectoderm marker) were examined. b-Actin was used as a loading control. C: In vivo differentiation of the three
OSK-induced NOD iPSC lines. Histologic analysis of teratomas indicates iPSCs contribute to tissues from the three germ layers, including kera-
tinized-epithelium (ectoderm), cartilage (mesoderm), and secreting-gland epithelium (endoderm). Tissues outlined by the dashed line are car-
tilage tissue. D: Contribution of NOD-iPS#5 cells in chimeric mouse (XA2401) as detected by agouti coat color. E: Hematopoietic chimerism
assessment by ﬂow cytometry analysis of spleen samples from a wild-type NOD mouse, the chimeric mouse (XA2401), and a C57BL/6 mouse.
Samples were stained for and gated on CD19
+ cells to identify B cells. Top: H-2K
b (C57BL/6) and H-2K
d (NOD) MHC class I expression on CD19
+
cells. Bottom: I-A
b (C57BL/6) and I-A
g7 (NOD) MHC class II expression on CD19
+ cells. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
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however, no albino offspring resulted from three litters
examined (18 pups born).
Last, we assessed the hematopoietic chimerism of male
XA2401 by cell surface marker expressions of the major
histocompatibility complex (MHC). NOD mice express
the MHC class I molecule K
d and class II molecule I-A
g7,
whereas C57BL/6 mice express K
b and I-A
b molecules,
respectively. Flow cytometric analysis of B-cell expres-
sion of MHC molecules in the spleen indicated that the
XA2401 mouse showed a C57BL/6 hematopoietic system
(Fig. 2E), despite a variegated coat color chimerism.
DISCUSSION
The major goal of our current research was to demonstrate
that somatic ﬁbroblasts from NOD mice can be reprog-
rammed to generate iPSCs. We used three Yamanaka fac-
tors, OCT4, SOX2, and KLF4, but not c-MYC, to fulﬁll the
reprogramming process of nTTF in this study. c-MYC was
excluded because previous studies have shown that po-
tential reactivation of the c-MYC transgene could result
in tumor development in the chimeras and their progeny
derived from the iPSCs (9,19). Instead, the chromatin
remodeling small-molecule VPA (a histone deacetylase
inhibitor) was used because it has been shown to greatly
increase the efﬁciency of reprogramming human and
mouse ﬁbroblasts (20,21). Male (XY) donor cells were also
chosen for induction to pluripotency for three reasons. 1)
Male pluripotent cell-derived differentiated cells are easier
to track in vivo, based on Y-chromosome speciﬁc probes,
when used for transplantation studies into female recipi-
ents. 2) Aberrant X-inactivation associated with female
(XX) ESC lines can result in XO cells, which compromises
euploidy of cells, chimera generation, and germ-line
transmission (22,23). 3) Male ESC chimeras can be rapidly
bred with more than one wild-type female to produce
multiple litters.
By using this modiﬁed approach, we show that NOD
iPSCs are readily generated from nTTFs by transduction
with retroviral vectors encoding OCT4, SOX2, and KLF4
and supplementation with VPA in the culture medium for 1
week. All three transgenes were silenced in the NOD
iPSCs, suggesting complete reprogramming of the somatic
nTTF. The NOD iPSCs could be dissociated into single
cells by trypsinization and maintained for .50 passages.
The NOD iPSCs derived in this study maintained ESC-like
pluripotent characteristics and did not convert to an epi-
blast stem (EpiS) cell-like state, which is characterized by
distinct colonies with ﬂat morphology (24,25). This con-
trasts with the ﬁndings of Hanna et al. (4), because their
NOD iPSCs appeared to be metastable and acquired an
alternative EpiS cell-like identity after removal of exoge-
nous KLF4 or cMyc factor expression. The EpiS cell col-
onies not only were morphologically distinct from mouse
ESCs but also lost the ability to be propagated after dis-
sociation into single cells by trypsinization. In our study,
the derivation and maintenance of NOD iPSCs were ach-
ieved without constitutive expression of KLF4 transgene
or addition of small molecules of GSK3/ERK pathway
inhibitors. This difference may be due to the source of
adult somatic tissue: we used nTTF, whereas Hanna et al.
(4) used NOD MEF. Nonetheless, our modiﬁed method
provides a robust alternative strategy for the generation of
ESC-like pluripotent stem cells from a nonpermissive
mouse strain without using embryos.
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